Overview

High Dose Ruxolitinib and Allogeneic Stem Cell Transplantation in Myelofibrosis Patients With Splenomegaly

Status:
RECRUITING
Trial end date:
2029-01-01
Target enrollment:
Participant gender:
Summary
To learn if giving ruxolitinib and busulfan before a stem cell transplant can help to reduce spleen size and help the transplant to succeed.
Phase:
PHASE2
Details
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborator:
Incyte Corporation
Treatments:
Busulfan
Cyclophosphamide
eltrombopag
fludarabine
fludarabine phosphate
Levetiracetam
Mesna
romiplostim
ruxolitinib
Tacrolimus